Zusammenfassung
Eine neuere Behandlungsalternative für pharmakorefraktäre Epilepsiepatienten stellt die tiefe Hirnstimulation (THS) dar. Aufgrund der positiven Erfahrungen mit der THS bei Bewegungsstörungen wie M. Parkinson, Tremor und Dystonien war ihre Zulassung bei Epilepsiepatienten mit erheblichen Erwartungen verbunden. Wie bei anderen Epilepsiebehandlungen wird der Erfolg der THS an den Aspekten Wirksamkeit und Verträglichkeit gemessen. Neben klinischen Studien erfolgen entsprechende Erhebungen aktuell auch in Form von Registern. Zur dauerhaften Anfallskontrolle sind hierbei Ergebnisse aus der Langzeitbeobachtung der Studie Stimulation of the Anterior Nucleus of the Thalamus for Epilepsy (SANTE) zu erwarten. Darüber hinaus versucht das Register des deutsch-österreichischen „Arbeitskreises Tiefe Hirnstimulation bei Epilepsien“, mögliche psychiatrische und kognitive Nebenwirkung zu erfassen, während das europäische „Medtronic Registry for Epilepsy“ (MORE) der Fa. Medtronic insbesondere Responder und optimale Stimulationsparameter im Fokus hat.
Abstract
Deep brain stimulation (DBS) is a new treatment option for pharmacorefractory epilepsy patients. Due to the positive experiences gained with DBS for movement disorders such as Parkinson’s disease, Tremor und dystonia, approval for epilepsy patients was accompanied by great expectations. The success of DBS is measured by the aspects of efficacy and tolerability, as with other forms of epilepsy treatment. In addition to clinical studies such data are also currently being collated in the form of registers. Results on the long-term observation of durable seizure control are expected from the Stimulation of the Anterior Nucleus of the Thalamus for Epilepsy (SANTE) study. Furthermore, the register of the German-Austrian “Arbeitskreis Tiefe Hirnstimulation bei Epilepsien” (working group on deep brain stimulation in epilepsy) is attempting to collect data on possible psychiatric and cognitive side effects whereas the European Medtronic Registry for Epilepsy (MORE) of the company Medtronic is focusing on responder and optimal stimulation parameters.
Literatur
Aldenkamp AP, Baker G, Pieters MS et al (2005) The Neurotoxicity Scale: the validity of a patient-based scale, assessing neurotoxicity. Epilepsy Res 20:229–239
Andrade DM, Zumsteg D, Hamani C et al (2006) Long-term follow-up of patients with thalamic deep brain stimulation for epilepsy. Neurology 66:1571–1573
Baker GA, Smith DF, Dewey M et al (1991) The development of a seizure severity scale as an outcome measure in epilepsy. Epilepsy Res 8:245–251
Baker GA, Smith DF, Jacoby A et al (1998) Liverpool Seizure Severity Scale revisited. Seizure 7:201–205
Benabid AL, Pollak P, Hommel M et al (1989) Treatment of Parkinson tremor by chronic stimulation of the ventral intermediate nucleus of the thalamus. Rev Neurol (Paris) 145:320–323
Boon P, Vonck K, De Herdt V et al (2007) Deep brain stimulation in patients with refractory temporal lobe epilepsy. Epilepsia 48:1551–1560
Chabardes S, Kahane P, Minotti L et al (2002) Deep brain stimulation in epilepsy with particular reference to the subthalamic nucleus. Epileptic Disord 4(Suppl 3):S83–S93
Chkhenkeli SA, Chkhenkeli IS (1997) Effects of therapeutic stimulation of nucleus caudatus on epileptic electrical activity of brain in patients with intractable epilepsy. Stereotact Funct Neurosurg 69:221–224
Cooper IS (1973) Effect of chronic stimulation of anterior cerebellum on neurological disease. Lancet 1:206
Cramer JA, Perrine K, Devinsky O et al (1998) Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory. Epilepsia 39:81–88
Fisher R, Salanova V, Witt T et al (2010) Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia 51:899–908
Goebel S, Fischer R, Ferstl R, Mehdorn HM (2009) Normative data and psychometric properties for qualitative and quantitative scoring criteria of the Five-point Test. Clin Neuropsychol 23:675–690
Hodaie M, Wennberg RA, Dostrovsky JO et al (2002) Chronic anterior thalamus stimulation for intractable epilepsy. Epilepsia 43:603–608
Kerrigan JF, Litt B, Fisher RS et al (2004) Electrical stimulation of the anterior nucleus of the thalamus for the treatment of intractable epilepsy. Epilepsia 45:346–354
Kertesz A, Nadkarni N, Davidson W, Thomas AW (2000) The Frontal Behavioral Inventory in the differential diagnosis of frontotemporal dementia. J Int Neuropsychol Soc 6:460–468
Knopman DS, Kramer JH, Boeve BF et al (2008) Development of methodology for conducting clinical trials in frontotemporal lobar degeneration. Brain 131: 2957–2968
Kwan P, Brodie MJ (2000) Early identification of refractory epilepsy. N Engl J Med 342:314–319
Lee KJ, Jang KS, Shon YM (2006) Chronic deep brain stimulation of subthalamic and anterior thalamic nuclei for controlling refractory partial epilepsy. Acta Neurochir Suppl 99:87–91
Lim SN, Lee ST, Tsai YT et al (2007) Electrical stimulation of the anterior nucleus of the thalamus for intractable epilepsy: a long-term follow-up study. Epilepsia 48:342–347
Morrell MJ, RNS System in Epilepsy Study Group (2011) Responsive cortical stimulation for the treatment of medically intractable partial epilepsy. Neurology 77:1295–1304
Osorio I, Frei MG, Sunderam S et al (2005) Automated seizure abatement in humans using electrical stimulation. Ann Neurol 57:258–268
Osorio I, Overman J, Giftakis J et al (2007) High frequency thalamic stimulation for inoperable mesial temporal epilepsy. Epilepsia 48:1561–1571
Salanova V, Fisher R, Sante (2012) Long term efficacy of the SANTE trial (Stimulation of the anterior nucleus of thalamus for epilepsy). Epilepsy Currents Suppl 13:123–124
Schulze-Bonhage A, Coenen V (2013) Treatment of epilepsy: peripheral and central stimulation techniques. Nervenarzt 84:517–528
Strauss E, Sherman EM, Spreen O (19986) A compendium of neuropsychological tests: administration, norms, and commentary, 2. Aufl. Oxford University Press, Oxford
Tombaugh TN (1996) The test of memory malingering. Multi-Health Systems, Toronto
Tombaugh TN, Hubley AM (1997) The 60-item Boston Naming Test: norms for cognitively intact adults aged 25 to 88 years. J Clin Exp Neuropsychol 19:922–932
Upton AR, Amin I, Garnett S et al (1987) Evoked metabolic responses in the limbic-striate system produced by stimulation of anterior thalamic nucleus in man. Pacing Clin Electrophysiol 10:217–225
Valentin A, Garcia Navarrete E, Chelvarajah R et al (2013) Deep brain stimulation of the centromedian thalamic nucleus for the treatment of generalized and frontal epilepsies. Epilepsia 54:1823–1833
Wright GD, McLellan DL, Brice JG (1984) A double-blind trial of chronic cerebellar stimulation in twelve patients with severe epilepsy. J Neurol Neurosurg Psychiatry 47:769–774
Einhaltung ethischer Richtlinien
Interessenkonflikt. B. Möller hat in der Vergangenheit Vortragshonorare und Reisekostenerstattungen von Medtronic erhalten. N. Lang hat in der Vergangenheit Vortragshonorare und Reiskostenerstattungen von Medtronic erhalten. Alle im vorliegenden Manuskript beschriebenen Untersuchungen am Menschen wurden mit Zustimmung der zuständigen Ethikkommission, im Einklang mit nationalem Recht sowie gemäß der Deklaration von Helsinki von 1975 (in der aktuellen, überarbeiteten Fassung) durchgeführt. Von allen beteiligten Patienten liegt eine Einverständniserklärung vor.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Möller, B., Lang, N. Register zur Thalamusstimulation bei Epilepsiepatienten. Z. Epileptol. 27, 42–47 (2014). https://doi.org/10.1007/s10309-013-0347-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10309-013-0347-x